tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksMost Visited WebsitesDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by Upside
New
Top ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
New
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Stock ScreenerETF Screener
Popular
Trending StocksDaily Analyst RatingsCompare StocksCompare ETFsPenny Stock ScreenerTechnical Analysis ScreenerDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Personal Finance CenterMortgagesLoansInvesting & RetirementSpending & Savings
Calculators
401k Retirement CalculatorMortgage Calculator
Popular
Compound Interest CalculatorDollar Cost Averaging
New
Student Loan CalculatorAuto Loan Calculator
Education
How To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsTop Online BrokersBecome an Affiliate
Follow Us
NewsTrendingPortfolio
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Top ETFs
Top Smart Score Stocks
Popular
Earnings
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
Most Visited Websites
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Stock Screener
ETF Screener
Popular
Trending Stocks
Daily Analyst Ratings
Compare Stocks
Compare ETFs
Penny Stock Screener
Technical Analysis Screener
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
Follow Us

IFRX Stock Latest News

InflaRx Announces $75M Share Sales Agreement
Company AnnouncementsInflaRx Announces $75M Share Sales Agreement
8d ago
6K
IFRX
InflaRx’s Drug Enters BARDA Phase 2 ARDS Trial
PremiumCompany Announcements
InflaRx’s Drug Enters BARDA Phase 2 ARDS Trial
12d ago
6K
IFRX
Barda selects InflaRx’s GOHIBIC for clinical trial to evaluate ARDS therapeutic
PremiumThe Fly
Barda selects InflaRx’s GOHIBIC for clinical trial to evaluate ARDS therapeutic
13d ago
IFRX
InflaRx’s GOHIBIC (Vilobelimab) Selected for First BARDA-Sponsored Clinical Trial to Evaluate Novel Host-Directed Therapeutics for Acute Respiratory Distress Syndrome (ARDS)
PremiumPress Releases
InflaRx’s GOHIBIC (Vilobelimab) Selected for First BARDA-Sponsored Clinical Trial to Evaluate Novel Host-Directed Therapeutics for Acute Respiratory Distress Syndrome (ARDS)
13d ago
IFRX
InflaRx Unveils INF904’s Market Potential
PremiumCompany Announcements
InflaRx Unveils INF904’s Market Potential
1M ago
6K
IFRX
InflaRx Hosts R&D Event Highlighting the Promise of INF904
PremiumPress ReleasesInflaRx Hosts R&D Event Highlighting the Promise of INF904
1M ago
IFRX
InflaRx’s Drug Shows Life-Saving Potential in COVID-19
PremiumCompany Announcements
InflaRx’s Drug Shows Life-Saving Potential in COVID-19
2M ago
6K
IFRX
InflaRx Presents New Analysis of PANAMO Phase III Trial in Severe COVID-19 at ATS 2024 Showing Potential Synergy With Vilobelimab When Used in Combination with Other Immunomodulators
PremiumPress Releases
InflaRx Presents New Analysis of PANAMO Phase III Trial in Severe COVID-19 at ATS 2024 Showing Potential Synergy With Vilobelimab When Used in Combination with Other Immunomodulators
2M ago
IFRX
InflaRx shares additional data, new analysis of PANAMO Phase III trial
PremiumThe Fly
InflaRx shares additional data, new analysis of PANAMO Phase III trial
2M ago
IFRX
InflaRx N.V. Reports Q1 2024 Financial Loss
PremiumCompany Announcements
InflaRx N.V. Reports Q1 2024 Financial Loss
2M ago
6K
IFRX
InflaRx reports Q1 EPS (EUR 0.17) vs. (EUR 0.25) last year
PremiumThe Fly
InflaRx reports Q1 EPS (EUR 0.17) vs. (EUR 0.25) last year
2M ago
IFRX
InflaRx N.V. Announces Share Capital Amendment
PremiumCompany Announcements
InflaRx N.V. Announces Share Capital Amendment
2M ago
6K
IFRX
InflaRx to Participate in Capital One Securities 1st Annual Biotech/Biopharma Disrupters Event
PremiumPress ReleasesInflaRx to Participate in Capital One Securities 1st Annual Biotech/Biopharma Disrupters Event
2M ago
IFRX
InflaRx N.V. Announces 2024 AGM Details
PremiumCompany Announcements
InflaRx N.V. Announces 2024 AGM Details
3M ago
6K
IFRX
InflaRx Advances Anti-Inflammatory Therapeutics
PremiumCompany Announcements
InflaRx Advances Anti-Inflammatory Therapeutics
4M ago
6K
IFRX
InflaRx N.V. Targets Immuno-Dermatology Growth
PremiumCompany Announcements
InflaRx N.V. Targets Immuno-Dermatology Growth
4M ago
6K
IFRX
InflaRx announces INF904 development plans
PremiumThe Fly
InflaRx announces INF904 development plans
4M ago
IFRX
InflaRx sees cash runway into at least 2026
PremiumThe Fly
InflaRx sees cash runway into at least 2026
4M ago
IFRX
InflaRx reports 2023 EPS (EUR 0.78) vs. (EUR 0.67) last year
PremiumThe Fly
InflaRx reports 2023 EPS (EUR 0.78) vs. (EUR 0.67) last year
4M ago
IFRX
InflaRx to Announce Development Plans for INF904 and 2023 Financial Results on March 21, 2024
PremiumPress ReleasesInflaRx to Announce Development Plans for INF904 and 2023 Financial Results on March 21, 2024
4M ago
IFRX
IFRX Earnings Report this Week: Is It a Buy, Ahead of Earnings?
PremiumPre-Earnings
IFRX Earnings Report this Week: Is It a Buy, Ahead of Earnings?
4M ago
IFRX
InflaRx appoints Medina as Head of Investor Relations
PremiumThe Fly
InflaRx appoints Medina as Head of Investor Relations
5M ago
IFRX

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >